Currently, Zymeworks BC Inc’s (ZYME) stock is trading at $23.53, marking a fall of -0.42% from last night’s close. At this price, the stock is -17.41% below its 52-week high of $28.49 and 160.58% above its 52-week low of $9.03.
As well, it is important to consider ZYME stock ratios such as price-to-sales, which is currently 13.19.ZYME’s price to book ratio for the most recent quarter was 5.57, resulting in an 7.04 price to cash per share for the period.
How does Zymeworks BC Inc (ZYME) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1.
Zymeworks BC Inc (ZYME): Earnings History
If we examine Zymeworks BC Inc’s recent earnings history, in the last quarter ended on 9/30/2025, it posted adjusted earnings per share of -$0.26, slashing the consensus of -$0.32. In other words, it beat the consensus by $0.06, resulting in a 17.83% surprise. In the 3 months period before the previous quarter which was closed on 9/30/2025, the stock recorded adjusted earnings per share of -$0.26 in contrast with the Outlook of -$0.32. That was a difference of $0.06 and a surprise of 17.83%.
Zymeworks BC Inc (NASDAQ: ZYME) Ownership Details
I will give a breakdown of the key shareholders in Zymeworks BC Inc (ZYME). Recent figures show that the company’s insiders hold 0.98% of shares. A total of 268 institutional investors hold shares in the company, making 99.17% of its stock and 100.15% of its float.
Sep 30, 2025, it was reported that the Company’s largest institutional holder is EcoR1 Capital, LLC holding total of 22.97 shares that make 36.46% of the company’s total number of shares and are currently priced at 539.46 million.
The securities firm Rubric Capital Management LP holds 4.71 shares of ZYME, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 7.48%, and the holding percentage of shares is valued at 110.63 million.
